Image

Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes

Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes

Recruiting
18-40 years
Female
Phase N/A

Powered by AI

Overview

Standardized longitudinal data collection of diabetes management relevant factors in women with T1D (insulin requirements, glucose variability, nutritional information, and menstrual cycle information) to identify categories of cycle trajectories.

Eligibility

Inclusion criteria:

  • Female sex
  • Between 18 and 40 years at inclusion
  • Menarche at least one year prior to study inclusion
  • Regular menstrual cycle (at least one menstrual cycle in the last 40 days)
  • Average menstrual cycle length between 21 and 38 days
  • Difference in length between consecutive menstrual cycles of at most 7 days
  • Living with type 1 diabetes or latent autoimmune diabetes in adults (LADA) for at least one year
  • Actively using an AID system for their diabetes management at least six months prior to study inclusion

Exclusion criteria:

  • Regular hormonal intake (e.g. corticosteroids), except: insulin, stable thyroid substitution, and hormonal contraception
  • Pregnancy until two months postpartum (ongoing or planned)
  • Current breastfeeding (including pumping), as well as two months following complete cessation of breastfeeding and pumping
  • Known Polycystic Ovary Syndrome (PCOS)
  • Intake of glucocorticoid medication, agents affecting gastric emptying, oral anti-diabetic agents (Metformin) or SGLT-2 inhibitors or GLP-1-analogs
  • Individuals with work patterns involving frequent shifts between night and day work (e.g., alternating night and day shifts on a weekly or similar basis).
  • Participation in an interventional study within two months preceding and during the present study

Study details
    Diabetes Mellitus
    Type 1

NCT06282055

DCB Research AG

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.